<DOC>
	<DOCNO>NCT00501241</DOCNO>
	<brief_summary>The purpose study determine whether ATI-7505 effective treatment chronic idiopathic constipation .</brief_summary>
	<brief_title>Phase II , Randomized , Placebo-Controlled Study ATI-7505 Patients With Chronic Idiopathic Constipation</brief_title>
	<detailed_description>This study design evaluate safety efficacy ATI 7505 generally healthy , adult patient symptom chronic idiopathic constipation least 6 month define ROME III criterion .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>ATI 7505</mesh_term>
	<criteria>write informed consent 18 75 year age constipation symptom onset least 6 month ago &amp; meet ROME III criterion chronic constipation negative colonoscopy air contrast barium enema within past 2 year â‰¥50 year age within past 5 year &lt; 50 year age ; able refrain use medication know treat constipation associate symptom throughout study transabdominal surgery , unstable coronary artery disease , organic gastrointestinal disease , collagen vascular disease , alarm symptom within 6 month prior screen ; take prohibit medication ( include laxative , herbal remedy ) participate another drug medical device study use investigational drug within 30 day dose planning use prior study completion ; QTcB &gt; 440 msec , abnormal 12lead ECG , family history sudden death age &lt; 40 year history long QT syndrome alcohol drug abuse within 6 month prior screen ; autonomic dyssynergic defecation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>